A considerable percentage of BC in postmenopausal women is due to obesity due to subclinical chronic inflammation and alterations in hormonal systems, including sex steroid hormones as well as peptide metabolic hormones, such as insulin, bioavailable insulin growth factor (IFG)-1, and adipokines [1,46]. This evidence concerns the gene IFNG and obesity due to melanocortin 4 receptor deficiency.